GLP-1 insurance denial appeal: a calm step-by-step guide

Find the denial letter or portal message and look for the “reason for denial,” the drug name, and the date. Common reasons include prior authorization not approved, step therapy required, plan exclusion, missing diagnosis code, or “not medically necessary.” Write down the appeal deadline and where to send it (fax, portal, or mailing address). If any part is unclear, call the number on your insurance card and ask them to explain the denial reason in plain language.

Request the plan’s coverage criteria for the exact medication and indication (for example, weight management vs type 2 diabetes). Ask whether the drug is on the formulary, whether it requires prior authorization, and whether step therapy applies. Confirm which GLP-1 products your plan prefers, since some plans cover one brand but not another. Keep notes with the date, the name of the person you spoke with, and a reference number if they provide one.

Collect a recent medication list, your diagnosis list, and clinic notes that support why a GLP-1 was prescribed. Include objective measures your plan often asks for, like BMI history, weight trend, A1C history (if relevant), blood pressure readings, kidney labs, or documented cardiovascular history. If the denial mentions step therapy, gather records showing what you already tried, what happened, and why alternatives were not a fit. If you use a compounded version because of access or coverage gaps, document what you used and why, and discuss it with your prescribing clinician for accurate charting.

Ask your prescriber’s office for an appeal letter that directly answers the plan’s denial reason and cites the plan’s own criteria when possible. The letter should be specific: your diagnoses, the requested medication and dose form (pen, vial, or pill), and why it is appropriate for you. If the plan requires prior authorization, make sure the appeal includes the missing items that caused the denial (codes, visit notes, labs, or proof of step therapy). Do not change how you take any medication based on an appeal plan—use this step only to improve documentation and alignment with insurer rules.

Send the appeal using the method your insurer requires and include the denial letter, the appeal letter, and supporting records in one packet when possible. Keep proof of submission (fax confirmation, portal screenshot, or certified mail receipt). Call within a few days to confirm it was received and ask when a decision is expected. If your plan offers an expedited appeal, ask what qualifies and whether your prescriber can request it based on your situation.

If the appeal is pending, ask your pharmacist and insurer whether a temporary fill, exception process, or formulary alternative is available under your plan rules. If you are eligible for Medicare and the medication is for weight management, ask your plan about the CMS “Medicare GLP-1 Bridge” demonstration (in effect starting July 1, 2026) and whether your situation meets the prior authorization criteria. If you are paying cash, compare manufacturer channels and pricing tools at the time of writing, such as TrumpRx.gov listings that route to maker programs, and always confirm current price and eligibility directly with the manufacturer, your plan, or your pharmacist because programs change often. For the new GLP-1 pills, note that Wegovy pill must be taken first thing in the morning with a small sip of water at least 30 minutes before food, drinks, or other oral medicines, while Foundayo can be taken any time of day without fasting or water restrictions—your prescriber can help decide what fits your needs and coverage.